Navigation Links
Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
Date:9/16/2009

ALISO VIEJO, CA, Sept 14, 2009 / b3c newswire / Ambry Genetics announced today that they have completed certification to become an Agilent Certified Service Provider on the Agilent microarray platform. The initial certification is for Comparative Genomic Hybridization (aCGH) which is an application used by researchers to discover and detect genomic copy number variations within specific genomes.

The Certified Service Provider program comprises a select list of strategic organizations that pass a rigorous assessment to use Agilent's microarray platform. The program combines the provider's focused expertise with the complete Agilent microarray workflow to create specialized services or complete genomic research solutions.

We are thrilled to be the first Agilent Certified Service Provider on the West Coast of the United States, said Ardy Arianpour, Director of Business Development, Pharmaceutical Services at Ambry Genetics. Our Pharmaceutical, Biotech, and Academic customers will be able to receive the highest quality results and service with the CSP stamp of approval. This accomplishment continues to demonstrate Ambry Genetics dedication to our customers and the genomics services industry.

Array comparative genomic hybridization has become the approach of choice in research settings to comprehensively identify chromosomal imbalances throughout the genome, added Dr. Aaron Elliott, R&D Scientist, Ambry Genetics. Agilents wide variety of catalog arrays combined with a cost effective custom design capability available through Agilents eArray software allows us to provide our researchers with highly sensitive genome-wide scans at varying resolutions. Our CSP status further ensures our researchers that they are getting the best quality service available.



About Ambry Genetics - www.ambrygen.com
Ambry Genetics is a CAP-accredited, GLP-compliant, CLIA-certified commercial clinical laboratory headquartered in Aliso Viejo, California. Since the companys inception in 2000, it has become a leader in providing genetic services focused on clinical diagnostics, pharmacogenomics and research support services. Ambry has built a solid reputation for unparalleled service, and has been at the forefront of applying new technologies to the clinical molecular diagnostics market and advancements in disease research. To learn more about testing and services available through Ambry, visit www.ambrygen.com.


About Agilent Technologies - www.agilent.com
Agilent Technologies Inc. (NYSE: A) is the worlds premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The companys 18,000 employees serve customers in more than 110 countries. Agilent had net revenues of $5.8 billion in fiscal 2008.



Contact:
Jeff Owen
phone +1-949-900-5542
e-mail: jowen@ambrygen.com


'/>"/>
b3c newswire

Related biology news :

1. Dartmouth researchers get personal with genetics
2. New book offers practical advice for unraveling the genetics of complex human diseases
3. New piece found in the puzzle of epigenetics
4. Opposites attract -- how genetics influences humans to choose their mates
5. 100 reasons to change the way we think about genetics
6. ACLU -- Myriad Genetics lawsuit will become landmark case
7. American College of Medical Genetics affirms importance of newborn screening dried blood spots
8. New nucleotide could revolutionize epigenetics
9. For cancer cells, genetics alone is poor indicator for drug response
10. Major aspergillus genomics supplement published by journal Fungal Genetics and Biology
11. Ali Shilatifard and colleagues aim to clarify the definition of epigenetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2016)... 17, 2016 Global Market Watch: Primarily ... Banks, Population-Based Banks and Academics) market is to witness a ... Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of ... during the analysis period 2014-2020. North America ... followed by Europe at 9.56% respectively. ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... 2016 , ... DrugDev believes the only way to achieve real ... All three tenets were on display at the 2nd Annual DrugDev User Summit (hosted ... CRO and site organizations to discuss innovation and the future of clinical research. ...
(Date:12/2/2016)... 2, 2016 The immunohistochemistry (IHC) market ... a CAGR of 7.3% during the forecast period of 2016 to ... laboratories segment accounted for the largest share of immunohistochemistry (IHC) market, ... , ... immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies and ...
(Date:11/30/2016)... 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the ... excited to announce the formation of EyGen, Ltd. ... ophthalmology assets through proof of concept. EyGen,s lead ... Portage Pharmaceuticals Limited and being developed for topical ... anterior segment diseases. This agent has the potential ...
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 Novogene ... services and solutions with cutting edge next-generation sequencing (NGS) ... a USD $75 Million [515 Million RMB] B round ... Capital Management ( Shenzhen ) Co., Ltd. ... Innovation") and Shanghai Sigma Square Investment Center LP ("Sigma ...
Breaking Biology Technology: